Atricure Inc risk profile

35 Normal where most of the sector sits

Measured 1 September 2026 from ATRC's filed statements. Recomputed nightly.

35 (Normal), driven by Competitive position at 50, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation34NormalVolatileOne-year price volatility — 47.2%
Operating pressure16ContainedEasingCosts outgrowing revenue — -7.2 percentage points
Cash conversion26NormalEasingCapital spending against operating cash — 0.16x
Leverage and coverage24NormalEasingInterest cover — 2.76x
Competitive position50ElevatedStableOperating-margin gap against peers — -4.8 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Atricure Inc